Literature DB >> 266193

Partial amino acid sequence of two major component polypeptides of hepatitis B surface antigen.

D L Peterson, I M Roberts, G N Vyas.   

Abstract

Determination of the amino acid sequence of the immunogenic polypeptides of hepatitis B surface antigen may not only permit molecular localization of the distinct determinants a, d, and y but may also lead to the synthesis of a hapten useful in prophylactic immunization against hepatitis B virus infection. For this purpose, purified monotypic hepatitis B surface antigen of adw subtype was resolved into equal amounts of two major polypeptides (22,000 and 28,000 daltons) and up to six other minor polypeptides by polyacrylamide gel electrophoresis. With the periodate staining reaction, only the 28,000-dalton polypeptide stained as a glycoprotein. Guinea pigs immunized with the 22,000-dalton polypeptide produced potent antisera against determinants a and d, but the 28,000-dalton glycoprotein did not induce a response. Both polypeptides isolated by preparative polyacrylamide gel electrophoresis showed amino acid composition identical with that of the intact antigen. For both polypeptides, hydrazinolysis gave Ile as the carboxyterminus, and carboxypeptidase A digestion gave the same terminal sequence, Val-Tyr-Ile. Both peptides also yielded an identical sequence of amino acids in nine steps of Edman degradation--Met-Glu-Asn-Ile-Thr-Ser(Cys)-Gly-Phe-Leu. Our data suggest that hepatitis B surface antigen contains a single major immunogenic 22,000-dalton polypeptide component, part of which is modified by the addition of carbohydrate to give rise to the glycopeptide of apparent molecular weight 28,000.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266193      PMCID: PMC430823          DOI: 10.1073/pnas.74.4.1530

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  C-Terminal groups in myosin, tropomyosin and actin.

Authors:  R H LOCKER
Journal:  Biochim Biophys Acta       Date:  1954-08

2.  Biochemical characterization of hepatitis B surface antigen in relation to serologic activity.

Authors:  K R Rao; G N Vyas
Journal:  J Biol Stand       Date:  1976

3.  Purification and characterization of lipoprotein lipase from pig adipose tissue.

Authors:  A Bensadoun; C Ehnholm; D Steinberg; W V Brown
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  Editorial: Subtypes of hepatitis B antigen: clinical relevance?

Authors:  G L Le Bouvier
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

5.  Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds.

Authors:  G N Vyas; K R Rao; A B Ibrahim
Journal:  Science       Date:  1972-12-22       Impact factor: 47.728

6.  Separation and purification of hepatitis-associated antigen into morphologic types by zonal ultracentrifugation.

Authors:  H E Bond; W T Hall
Journal:  J Infect Dis       Date:  1972-03       Impact factor: 5.226

7.  Virus-like particles in serum of patients with Australia-antigen-associated hepatitis.

Authors:  D S Dane; C H Cameron; M Briggs
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

8.  Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

Authors:  G R Dreesman; F B Hollinger; J R Suriano; R S Fujioka; J P Brunschwig; J L Melnick
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

9.  The hepatic microsomal metabolism of beta-3,4-methylenedioxyamphetamine (MDA).

Authors:  G M Marquardt; V DiStefano
Journal:  Life Sci       Date:  1974-11-01       Impact factor: 5.037

10.  Purification and biophysical characterization of hepatitis B antigen.

Authors:  C Y Kim; J G Tilles
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

View more
  34 in total

1.  Isolation and functional property of mRNA coding for hepatitis A, B, and non A-non B viral particles from human sera.

Authors:  A A Hakim
Journal:  Naturwissenschaften       Date:  1986-01

2.  Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame.

Authors:  D T Wong; N Nath; J J Sninsky
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

Review 3.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Tree squirrel hepatitis B virus: antigenic and structural characterization.

Authors:  M A Feitelson; I Millman; B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles.

Authors:  R A Lerner; N Green; H Alexander; F T Liu; J G Sutcliffe; T M Shinnick
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

6.  Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus.

Authors:  W H Gerlich; M A Feitelson; P L Marion; W S Robinson
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

7.  Major polypeptide of duck hepatitis B surface antigen particles.

Authors:  P L Marion; S S Knight; M A Feitelson; L S Oshiro; W S Robinson
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

8.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

9.  Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells.

Authors:  C W Crowley; C C Liu; A D Levinson
Journal:  Mol Cell Biol       Date:  1983-01       Impact factor: 4.272

10.  Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.

Authors:  D R Milich; M K McNamara; A McLachlan; G B Thornton; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.